Could heparin offer new hope in the fight against dementia?

Heparin therapy delays Alzheimer’s diagnosis by one to two years, offering potential insights into new protective treatments. Large-scale health records show a promising association between the anticoagulant and delayed dementia onset.

OneStep Secures $36M for AI-Powered Gait Analysis

What You Should Know: – OneStep, a provider of smartphone-based motion analysis technology has raised $36M in funding co-led by Team8 and Vintage Investment Partners.

October 22, 2024

FDA says Merz’s social media promotion with Nate Berkus is ‘misleading’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 15, 2024

Updates on MDMA, Ketamine, and the Future of Psychedelic Therapies

Table of Contents Over the last few weeks, the federal government has taken a number of actions that signal a dark future for psychedelic therapies.

August 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.